418 related articles for article (PubMed ID: 26447782)
21. Evaluation of ferrocenyl phosphines as potent antimalarials targeting the digestive vacuole function of Plasmodium falciparum.
Subramanian G; Sadeer A; Mukherjee K; Kojima T; Tripathi P; Naidu R; Tay SW; Pang JH; Pullarkat SA; Chandramohanadas R
Dalton Trans; 2019 Jan; 48(3):1108-1117. PubMed ID: 30605200
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline.
Kondaparla S; Manhas A; Dola VR; Srivastava K; Puri SK; Katti SB
Bioorg Chem; 2018 Oct; 80():204-211. PubMed ID: 29940342
[TBL] [Abstract][Full Text] [Related]
24. Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties.
Ekengard E; Kumar K; Fogeron T; de Kock C; Smith PJ; Haukka M; Monari M; Nordlander E
Dalton Trans; 2016 Mar; 45(9):3905-17. PubMed ID: 26829897
[TBL] [Abstract][Full Text] [Related]
25. Ferrocene-pyrimidine conjugates: Synthesis, electrochemistry, physicochemical properties and antiplasmodial activities.
Chopra R; de Kock C; Smith P; Chibale K; Singh K
Eur J Med Chem; 2015 Jul; 100():1-9. PubMed ID: 26057222
[TBL] [Abstract][Full Text] [Related]
26. Ferroquine and its derivatives: new generation of antimalarial agents.
Wani WA; Jameel E; Baig U; Mumtazuddin S; Hun LT
Eur J Med Chem; 2015 Aug; 101():534-51. PubMed ID: 26188909
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of phenylequine for antimalarial activity in vitro and in vivo.
Blackie MA; Yardley V; Chibale K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1078-80. PubMed ID: 20034790
[TBL] [Abstract][Full Text] [Related]
28. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Nqoro X; Aderibigbe BA
Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L
Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
[TBL] [Abstract][Full Text] [Related]
31. Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies.
Singh K; Kaur H; Smith P; de Kock C; Chibale K; Balzarini J
J Med Chem; 2014 Jan; 57(2):435-48. PubMed ID: 24354322
[TBL] [Abstract][Full Text] [Related]
32. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
Peter S; Aderibigbe BA
Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
[TBL] [Abstract][Full Text] [Related]
33. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK
Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399
[TBL] [Abstract][Full Text] [Related]
34. Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.
Dubar F; Khalife J; Brocard J; Dive D; Biot C
Molecules; 2008 Nov; 13(11):2900-7. PubMed ID: 19020475
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of chiral chloroquine and its analogues as antimalarial agents.
Sinha M; Dola VR; Soni A; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
Bioorg Med Chem; 2014 Nov; 22(21):5950-60. PubMed ID: 25284252
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines.
De D; Krogstad FM; Byers LD; Krogstad DJ
J Med Chem; 1998 Dec; 41(25):4918-26. PubMed ID: 9836608
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
[TBL] [Abstract][Full Text] [Related]
39. 1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: synthesis and antimalarial evaluation.
Raj R; Gut J; Rosenthal PJ; Kumar V
Bioorg Med Chem Lett; 2014 Feb; 24(3):756-9. PubMed ID: 24424135
[TBL] [Abstract][Full Text] [Related]
40. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
Manohar S; Khan SI; Rawat DS
Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
